Statistics

Total Visits

Views
A randomized phase II study of raltitrexed and gefitinib versus raltitrexed alone as second line chemotherapy in patients with colorectal cancer. (1839IL/0143)87

Select a period of time:

Number of views in the range

Views
A randomized phase II study of raltitrexed and gefitinib versus raltitrexed alone as second line chemotherapy in patients with colorectal cancer. (1839IL/0143)15

Views

Views
September 20251
October 20252
November 20252
December 20251
January 20263
February 20260
March 20266
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States4
United Kingdom3
Finland3
Argentina1
Canada1
Chile1
Spain1
Turkey1
 

Top cities views

Views
Helsinki3
Adana1
Almansa1
Annapolis1
Beachwood1
Formosa1
Santiago1